530 results on '"Pahl, Heike L."'
Search Results
2. GPRC5C drives branched-chain amino acid metabolism in leukemogenesis
3. Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy
4. The transcription factor NFE2 enhances expression of the hematopoietic master regulators SCL/TAL1 and GATA2
5. Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice
6. Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms
7. Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs
8. The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia
9. Treatment of Melanoma Cells with the Synthetic Retinoid CD437 Induces Apoptosis via Activation of AP-1 in Vitro, and Causes Growth Inhibition in Xenografts in Vivo
10. Activation of Transcription Factor NF-κB by the Adenovirus E3/19K Protein Requires Its ER Retention
11. Ponatinib: A Third-Generation Inhibitor for the Treatment of CML
12. Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
13. Characterization of PRV-1, a Novel Hematopoietic Cell Surface Marker Overexpressed in Polycythemia Rubra Vera
14. Tissue microarray technique is applicable to bone marrow biopsies of myeloproliferative neoplasms
15. The AML1/ETO target gene LAT2 interferes with differentiation of normal hematopoietic precursor cells
16. Subcellular mislocalization of the transcription factor NF-E2 in erythroid cells discriminates prefibrotic primary myelofibrosis from essential thrombocythemia
17. Activation of Cellular Death Programs Associated with Immunosenescence-Like Phenotype in TPPII Knockout Mice
18. Sentinel mutations: the roses in the vineyard
19. AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2
20. Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry
21. Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German Study Group for MPN Bioregistry
22. Clinical and hematological presentation of children and adolescents with polycythemia vera
23. Pharmacological Inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) Alone or in Combination With Ruxolitinib Shows Therapeutic Efficacy in Preclinical Myeloproliferative Neoplasm Models
24. Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf
25. Activators and target genes of Rel/NF-κB transcription factors
26. p38β-regulated induction of the heat shock response by carbon monoxide releasing molecule CORM-2 mediates cytoprotection in lung cells in vitro
27. Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO (RUNX1/RUNX1T1), during myeloid differentiation
28. Krüppel-like factor 15 regulates BMPER in endothelial cells
29. NF-E2 overexpression delays erythroid maturation and increases erythrocyte production
30. Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera
31. Essential Versus Reactive Thrombocythemia in Children: Retrospective Analyses of 12 Cases
32. A phase II trial of pegylated interferon α-2b therapy for polycythemia vera and essential thrombocythemia: Feasibility, clinical and biologic effects, and impact on quality of life
33. The ER-overload response: activation of NF-kappa
34. The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera
35. A phase II trial of pegylated interferon (alpha)-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life
36. Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2
37. Tyrosine phosphorylation of IkappaB-alpha, activates NF-kappaB without proteolytic degradation of IkappaB-alpha
38. Activation of transcription factor NF-kappa-B by the adenovirus E3/19K protein requires its ER retention
39. Isoflurane pretreatment lowers portal venous resistance by increasing hepatic heme oxygenase activity in the rat liver in vivo
40. Familial polycythemia vera with Budd–Chiari syndrome in childhood
41. Oxygen and the control of gene expression
42. Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis
43. [15]Identification of transcription factors and their target genes
44. Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice
45. Water pipe smoking as a cause of secondary erythrocytosis
46. The Immunosuppressive Fungal Metabolite Gliotoxin Specifically Inhibits Transcription Factor NF-κB
47. Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment
48. LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease Clone
49. Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
50. Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms : an analysis by the MPN QOL International Working Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.